Neisseria Meningitidis Completed Phase 2 Trials for Pentetic acid (DB14007)

DBCOND0030896 (Neisseria Meningitidis)Completed2 IdentifierTitlePurposeDrugs
NCT00127855Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) VaccinePrevention
NCT001291163 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of AgePrevention
NCT00871338Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in InfantsPrevention